Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GILD | Common Stock | Options Exercise | +3.68K | +11.05% | 37K | Aug 10, 2024 | Direct | F1 | ||
transaction | GILD | Common Stock | Tax liability | -$72.2K | -980 | -2.65% | $73.66 | 36K | Aug 10, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GILD | Restricted Stock Unit | Options Exercise | -3.68K | -20.71% | 14.1K | Aug 10, 2024 | Common Stock | 3.68K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
F2 | The restricted stock units have a three year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested. |